These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 7808201
1. Neutropenia and fever in patients receiving chemotherapy in a community teaching hospital: results of a retrospective chart review. Obadina M, Cho C, Oketunji A, Waterfield W. Md Med J; 1994 Nov; 43(11):977-80. PubMed ID: 7808201 [Abstract] [Full Text] [Related]
2. Emergency Department evaluation of patients with fever and chemotherapy-induced neutropenia. Perrone J, Hollander JE, Datner EM. J Emerg Med; 2004 Aug; 27(2):115-9. PubMed ID: 15261351 [Abstract] [Full Text] [Related]
3. Retrospective review of gynecologic oncology patients with therapy-induced neutropenic fever. McMeekin DS, Gazzaniga C, Berman M, DiSaia P, Manetta A. Gynecol Oncol; 1996 Aug; 62(2):247-53. PubMed ID: 8751557 [Abstract] [Full Text] [Related]
4. Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey. Tezcan G, Kupesiz A, Ozturk F, Ogunc D, Gultekin M, Yesilipek A, Hazar V. Pediatr Hematol Oncol; 2006 Aug; 23(3):217-29. PubMed ID: 16517538 [Abstract] [Full Text] [Related]
5. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients. Baskaran ND, Gan GG, Adeeba K. Ann Hematol; 2008 Jul; 87(7):563-9. PubMed ID: 18437382 [Abstract] [Full Text] [Related]
6. [Chemotherapy-induced febrile neutropenia: about 200 episodes. Clinical, microbiological and therapeutic characteristics]. Gharbi O, Ben Hadj Hassen S, Kaabia N, Limam S, Hadj Amor M, Ben Fatma L, Landolsi A, Hochlef M, Letaief A, Boukadida J, Ben Ahmed S. Pathol Biol (Paris); 2008 May; 56(3):154-7. PubMed ID: 18178025 [Abstract] [Full Text] [Related]
7. Development and implementation of a risk assessment tool for chemotherapy-induced neutropenia. Donohue R. Oncol Nurs Forum; 2006 Nov 03; 33(2):347-52. PubMed ID: 16518450 [Abstract] [Full Text] [Related]
8. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever. Chayakulkeeree M, Thamlikitkul V. J Med Assoc Thai; 2003 Mar 03; 86(3):212-23. PubMed ID: 12757060 [Abstract] [Full Text] [Related]
9. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime. Raad II, Escalante C, Hachem RY, Hanna HA, Husni R, Afif C, Boktour MR, Whimbey EE, Kontoyiannis D, Jacobson K, Kantarjian H, Levett LM, Rolston KV. Cancer; 2003 Sep 01; 98(5):1039-47. PubMed ID: 12942573 [Abstract] [Full Text] [Related]
10. High-risk febrile neutropenia in Auckland 2003-2004: the influence of the microbiology laboratory on patient treatment and the use of pathogen-specific therapy. Ritchie S, Palmer S, Ellis-Pegler R. Intern Med J; 2007 Jan 01; 37(1):26-31. PubMed ID: 17199841 [Abstract] [Full Text] [Related]
11. Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia. Hodgson-Viden H, Grundy PE, Robinson JL. BMC Pediatr; 2005 May 18; 5(1):10. PubMed ID: 15904510 [Abstract] [Full Text] [Related]
12. Clinical characteristics and therapeutic outcome of patients with febrile neutropenia who present in shock: need for better strategies. Malik I, Hussain M, Yousuf H. J Infect; 2001 Feb 18; 42(2):120-5. PubMed ID: 11531318 [Abstract] [Full Text] [Related]
13. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia. Ghalaut PS, Sen R, Dixit G. J Assoc Physicians India; 2008 Dec 18; 56():942-4. PubMed ID: 19322972 [Abstract] [Full Text] [Related]
14. The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation. Talcott JA, Finberg R, Mayer RJ, Goldman L. Arch Intern Med; 1988 Dec 18; 148(12):2561-8. PubMed ID: 3196123 [Abstract] [Full Text] [Related]
15. Febrile neutropenia in children with cancer: a retrospective Norwegian multicentre study of clinical and microbiological outcome. Stabell N, Nordal E, Stensvold E, Gammelsrud KW, Lund B, Taxt A, Buhring F, Greve-Isdahl M, Fornebo HP, Simonsen GS, Klingenberg C. Scand J Infect Dis; 2008 Dec 18; 40(4):301-7. PubMed ID: 17918015 [Abstract] [Full Text] [Related]
16. Risk assessment and microbiological profile of infections in paediatric cancer patients with febrile neutropenia. Latiff Z, Zulkifli SZ, Jamal R. Malays J Pathol; 2002 Dec 18; 24(2):83-9. PubMed ID: 12887165 [Abstract] [Full Text] [Related]
17. Analysis of the value of empiric vancomycin administration in febrile neutropenia occurring after autologous peripheral blood stem cell transplants. Koya R, Andersen J, Fernandez H, Goodman M, Spector N, Smith R, Hanlon J, Cassileth PA. Bone Marrow Transplant; 1998 May 18; 21(9):923-6. PubMed ID: 9613785 [Abstract] [Full Text] [Related]
18. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group. Ozkaynak MF, Krailo M, Chen Z, Feusner J. Pediatr Blood Cancer; 2005 Sep 18; 45(3):274-80. PubMed ID: 15806544 [Abstract] [Full Text] [Related]
19. NCCN: Fever and neutropenia. Wade JC, Rubenstein EB, NCCN Fever and Neutropenia Practice Guidelines Panel. Cancer Control; 2001 Sep 18; 8(6 Suppl 2):16-21. PubMed ID: 11760554 [No Abstract] [Full Text] [Related]
20. Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia. Girmenia C, Russo E, Carmosino I, Breccia M, Dragoni F, Latagliata R, Mecarocci S, Morano SG, Stefanizzi C, Alimena G. Ann Hematol; 2007 Apr 18; 86(4):263-70. PubMed ID: 17225113 [Abstract] [Full Text] [Related] Page: [Next] [New Search]